Best Practices For Pharmaceutical Waste

As more and more pharmaceutical companies launch into new projects, an even greater amount of pharmaceuticals are secreted into the environment. “Sustainability” has become commonplace in operational discussions; however, companies are still working toward that end. According to statistics reported by WHO, 15 percent of waste generated by health-care activities is considered to be hazardous: infectious, toxic, or radioactive. Washington State’s Department of Ecology explains the process of direct disposal of these pharmaceuticals: If disposed of or excreted to the sewer, pharmaceuticals are sent to [...]

By | 2017-12-18T21:47:53+00:00 May 24th, 2016|News|0 Comments

New Research Highlights Ability Of PURAPLY™ AND PURAPLY Antimicrobial (AM)™ To Manage BIOBURDEN And Support Healing Across Variety Of Wound Types

Canton, Mass. – Three new research abstracts presented at the recent 2016 Symposium on Advanced Wound Care (SAWC) highlight the role of PuraPly™ and PuraPly Antimicrobial (AM)™ – two new FDA-cleared collagen matrix products from Organogenesis Inc. – in managing bioburden and supporting wound healing across a variety of wound types. The first study, one of the SAWC/WHS spring oral abstract winners, was presented by researchers from the University of Miami Miller School of Medicine. This study used a porcine wound model to [...]

By | 2017-12-18T21:49:04+00:00 May 18th, 2016|News|0 Comments

Robust New Features Give Capital Market Customers s Time Advantage, Enabling Them To Immediately Identify Trading Anomalies Typically Missed With Traditional Displays

BEDFORD, Mass.  – Datawatch Corporation (NASDAQ-CM: DWCH) today announced the general availability of Datawatch Panopticon 13.7, providing faster visual data analysis for trading, risk and compliance markets. The new powerful features enable buy-side and sell-side firms, and exchanges to perform big data analysis of e-trading data both in real-time as well as intra-day and historically to gain insights that speed decision making. Regulatory demands in the U.S. and Europe have made order transparency essential. However, the fragmentation of liquidity, increased data volumes and the [...]

By | 2017-11-02T17:46:37+00:00 May 16th, 2016|News|0 Comments

CYBEX Receives Presidential Award For Export Successes Latest Brunswick Acquisition Cited For Contributions To U.S. Export

Rosemont, IL — U.S. Secretary of Commerce Penny Pritzker today presented Cybex International with the President’s “E” Star Award for Exports at a ceremony in Washington, DC. The President’s “E” Award is the highest recognition any U.S. entity can receive for making a significant contribution to the expansion of U.S. exports. “Cybex International has demonstrated a sustained commitment to export expansion. The “E” Awards Committee was very impressed with Cybex International’s customization of its products for export markets,” said Secretary Pritzker [...]

By | 2017-12-18T21:50:26+00:00 May 16th, 2016|News|0 Comments

Award-Winning Research From The Universality Of Miami Evaluates APLIGRAF’S®Role In Reversing a Chronic Wound Environment

Canton, Mass. – Award-winning research from a multidisciplinary team at the University of Miami provides new insight on what happens to a patient’s genomic profile when Apligraf®, an FDA-approved, bioengineered living cell-based therapy from Organogenesis Inc., is applied to a chronic venous leg ulcer (VLU), when compared to conventional therapy alone. The analysis found that Apligraf altered specific molecular and cellular responses in the wound environment, reversing the chronic wound profile to resemble more of an acute wound profile. “This [...]

By | 2017-12-18T21:49:50+00:00 May 11th, 2016|News|0 Comments